When did BOLT BIOTHERAPEUTICS INC (BOLT) report earnings last quarter?
BOLT BIOTHERAPEUTICS INC (BOLT) last reported earnings on 3/12/2026.
NASDAQ:BOLT • US0977022039
Past quarterly earnings results for BOLT BIOTHERAPEUTICS INC (BOLT), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | -3.84 | -6.23 | 38.35% | 49.47% | 2.5M | 680.003K | 267.65% | - |
| Q3 2025 | -3.72 | -5.90 | 36.99% | 53.50% | 2.169M | 739.5K | 193.31% | 90.10% |
| Q2 2025 | -4.46 | -6.58 | 32.21% | 51.52% | 1.804M | 836.145K | 115.75% | 41.49% |
| Q1 2025 | -5.80 | -7.40 | 21.57% | -3.57% | 1.222M | 782.85K | 56.10% | -76.83% |
| Q4 2024 | -7.60 | -7.75 | 1.96% | 19.15% | 805.8K | -100.00% | -100.00% | |
| Q3 2024 | -8.00 | -7.19 | -11.25% | 6.98% | 1.141M | 1.288M | -11.41% | -54.87% |
| Q2 2024 | -9.20 | -9.79 | 6.05% | 4.17% | 1.275M | 909.33K | 40.21% | -11.03% |
| Q1 2024 | -5.60 | -10.40 | 46.17% | 37.78% | 5.274M | 2.105M | 150.55% | 188.83% |
| Q4 2023 | -9.40 | -9.83 | 4.34% | 11.32% | 2.089M | 1.747M | 19.58% | 48.16% |
| Q3 2023 | -8.60 | -10.20 | 15.69% | 25.86% | 2.528M | 1.76M | 43.64% | 19.81% |
| Q2 2023 | -9.60 | -9.93 | 3.30% | 21.31% | 1.433M | 1.939M | -26.10% | 3.09% |
| Q1 2023 | -9.00 | -10.44 | 13.78% | 29.69% | 1.826M | 1.332M | 37.09% | 125.43% |
| Q4 2022 | -10.60 | -12.21 | 13.16% | 27.40% | 1.41M | 1.254M | 12.44% | 176.47% |
| Q3 2022 | -11.60 | -11.49 | -0.94% | 7.94% | 2.11M | 1.004M | 110.16% | 181.33% |
| Q2 2022 | -12.20 | -13.82 | 11.73% | 4.69% | 1.39M | 382.5K | 263.40% | - |
| Q1 2022 | -12.80 | -14.64 | 12.55% | 43.86% | 810K | 382.5K | 111.76% | - |
| Q4 2021 | -14.60 | -16.69 | 12.51% | 94.99% | 510K | 382.5K | 33.33% | - |
| Q3 2021 | -12.60 | -13.31 | 5.34% | - | 750K | 382.5K | 96.08% | - |
| Q2 2021 | -12.80 | -8.77 | -45.92% | - | 3.4M | -100.00% | -100.00% | |
| Q1 2021 | -22.80 | -12.24 | -86.27% | - | - | -100.00% | ||
| Q4 2020 | -291.60 | -36.77 | -693.02% | - | 51K | -100.00% | - | |
| Q3 2020 | - | - | - | - | ||||
| Q2 2020 | - | - | 70K | - | - | |||
| Q1 2020 | - | - | 160K | - | - |
Notes
BOLT BIOTHERAPEUTICS INC (BOLT) last reported earnings on 3/12/2026.
BOLT BIOTHERAPEUTICS INC (BOLT) beat EPS estimates and beat revenue estimates in the most recent quarter.
In the last 4 quarters, BOLT BIOTHERAPEUTICS INC (BOLT) has beaten EPS estimates in 4 out of 4 releases.